ARTICLE | Company News
Biolex, Synthon deal
April 30, 2012 7:00 AM UTC
Synthon acquired Biolex's LEX System biologics manufacturing platform and preclinical compounds BLX-155 and BLX-301. The LEX System uses cultures of duckweed Lemna minor to develop pharmaceutical prot...